Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Total Non-Current Liabilities: 2020-2025

Historic Total Non-Current Liabilities for Biofrontera (BFRI) over the last 4 years, with Sep 2025 value amounting to $17.2 million.

  • Biofrontera's Total Non-Current Liabilities rose 50.75% to $17.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.2 million, marking a year-over-year increase of 50.75%. This contributed to the annual value of $16.4 million for FY2024, which is 13.27% down from last year.
  • According to the latest figures from Q3 2025, Biofrontera's Total Non-Current Liabilities is $17.2 million, which was down 29.26% from $24.3 million recorded in Q2 2025.
  • Over the past 5 years, Biofrontera's Total Non-Current Liabilities peaked at $29.0 million during Q4 2021, and registered a low of $9.7 million during Q2 2024.
  • Over the past 3 years, Biofrontera's median Total Non-Current Liabilities value was $16.2 million (recorded in 2023), while the average stood at $16.7 million.
  • Its Total Non-Current Liabilities has fluctuated over the past 5 years, first plummeted by 51.25% in 2024, then spiked by 149.05% in 2025.
  • Biofrontera's Total Non-Current Liabilities (Quarterly) stood at $29.0 million in 2021, then declined by 16.76% to $24.2 million in 2022, then decreased by 21.66% to $18.9 million in 2023, then dropped by 13.27% to $16.4 million in 2024, then skyrocketed by 50.75% to $17.2 million in 2025.
  • Its Total Non-Current Liabilities was $17.2 million in Q3 2025, compared to $24.3 million in Q2 2025 and $15.4 million in Q1 2025.